U.S. markets closed
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • Dow 30

    34,200.67
    +164.68 (+0.48%)
     
  • Nasdaq

    14,052.34
    +13.58 (+0.10%)
     
  • Russell 2000

    2,262.67
    +5.60 (+0.25%)
     
  • Crude Oil

    63.07
    -0.39 (-0.61%)
     
  • Gold

    1,777.30
    +10.50 (+0.59%)
     
  • Silver

    26.04
    +0.08 (+0.29%)
     
  • EUR/USD

    1.1980
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • GBP/USD

    1.3842
    +0.0058 (+0.42%)
     
  • USD/JPY

    108.7900
    +0.0740 (+0.07%)
     
  • BTC-USD

    61,784.97
    +378.86 (+0.62%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

Peru volunteer in Sinopharm vaccine trial dies of COVID-19 pneumonia, university says

  • Oops!
    Something went wrong.
    Please try again later.
Marco Aquino
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

By Marco Aquino

LIMA, Jan 26 (Reuters) - A volunteer in the local Peruvian trial of Sinopharm Group Co Ltd's coronavirus vaccine has died from COVID-19 related pneumonia, the university carrying out the trial said on Tuesday.

Cayetano Heredia University, which is involved with the study, said that it did not know if the volunteer had received the vaccine or the placebo in the double blind trial. Peru is being hit by a second wave of COVID-19 infections.

The university added that it had communicated the case to the study's safety committee and to regulatory authorities for an investigation to take place.

In December, Peru temporarily suspended trials of the Sinopharm COVID-19 vaccine due to a "serious adverse event" that occurred with a volunteer in the study. (Reporting by Marco Aquino; Writing by Adam Jourdan)